5 Best Debt Free Stocks To Buy
Incyte Corporation (NASDAQ:INCY) is a biopharmaceutical company that engages in the discovery, development, and commercialization of therapeutics for hematology and oncology.
Posts Tagged ‘NASDAQ:INCY’
Jim Simons Stock Portfolio: 12 Biggest Healthcare Stocks
In this piece, we will take a look at the 12 biggest healthcare stocks in Jim Simons' stock portfolio.
Top 20 Drug Companies in the US by Revenue
In this article, we will be taking a look at the top 20 drug companies in the US by revenue.
Incyte Corporation (NASDAQ:INCY) Q3 2023 Earnings Call Transcript
Operator: Hello, and welcome to the Incyte Third Quarter Earnings Conference Call. [Operator Instructions] A question-and-answer session will follow the formal presentation.
5 Cheap Biotech Stocks Smart Investors Are Piling Into
In this piece, we will take a look at five cheap biotechnology stocks that smart investors are piling into.
Top 30 Oncology Companies in the World
In this article, we shall cover the top 30 oncology companies in the world.
13 Best Beaten Down Stocks To Buy Now
In this article, we will be taking a look at the 13 best beaten down stocks to buy now.
15 Worst Performing Biotech Stocks in 2023
In this article, we discuss 15 worst performing biotech stocks in 2023.
Incyte Corporation (NASDAQ:INCY) Q2 2023 Earnings Call Transcript
Operator: Hello and welcome to the Incyte Second Quarter Earnings Conference Call and Webcast. [Operator Instructions] As a reminder, this conference is being recorded.
Incyte Corporation (NASDAQ:INCY) Q1 2023 Earnings Call Transcript
Operator: Hello and welcome to the Incyte First Quarter 2023 Earnings Call and Webcast. A question-and-answer session will follow the formal presentation.
Incyte Corporation (NASDAQ:INCY) Q4 2022 Earnings Call Transcript
Operator: Hello, and welcome to the Incyte Fourth Quarter and Full Year Financial Results Conference Call and webcast. As a reminder, this conference is being recorded.
12 Cheap Biotech Stocks To Buy
In this article, we will be taking a look at 12 cheap biotech stocks to buy.
Jim Simons Stock Portfolio: 10 Biggest Healthcare Stocks
In this article we take a look at Jim Simons Stock Portfolio: 10 Biggest Healthcare Stocks.
5 Best Pharmaceutical Stocks to Buy According to Steven Boyd’s Armistice Capital
In this article, we will take a look at some important pharma stock picks of Steven Boyd's Armistice Capital.
Analysts Are Downgrading These 10 Stocks
In this article, we will take a look at the 10 stocks that were recently downgraded by analysts.
5 Biotech Stocks to Buy According to Billionaire David E. Shaw
In this piece, we will take a look at five biotechnology stocks to buy according to billionaire David E. Shaw.
Hedge Fund and Insider Trading News: Clifford Asness, Farallon Capital Management, BlueCrest Capital Management, Marshall Wace LLP, Fir Tree Capital Management, Alden Global Capital, Aravt Global LLC, Reservoir Media Inc (RSVR), DoorDash, Inc. (DASH), and More
Hedge fund titan Clifford Asness joined traders in slamming the London Metal Exchange after the platform cancelled trades – a move that may have helped stem losses at a fund...
Did The Smart Money Get Incyte Corporation (INCY) Right?
The latest 13F reporting period has come and gone, and Insider Monkey have plowed through 867 13F filings that hedge funds and well-known value investors are required to file ...
Hedge Fund and Insider Trading News: Catherine Wood, Dan Loeb, Ray Dalio, Millennium Management, Chessica LP, Incyte Corporation (INCY), Verastem, Inc. (VSTM), and More
Billionaire investor Ray Dalio has said the Federal Reserve's tightening of monetary policy in 2022 shouldn't derail the economic expansion, but is likely to weigh heavily on "...
Here is What Hedge Funds Think About Incyte Corporation (INCY)
In this article you are going to find out whether hedge funds think Incyte Corporation (NASDAQ:INCY) is a good investment right now.
Hedge Funds Are Nibbling On Incyte Corporation (INCY)
While the market driven by short-term sentiment influenced by the accommodative interest rate environment in the US, virus news and stimulus spending, many smart money investors...
Why These 5 Stocks Are on the Move on Wednesday
In this article we take a look at five stocks on the move on Wednesday.
Hedge Funds Are Selling Incyte Corporation (INCY)
The financial regulations require hedge funds and wealthy investors that exceeded the $100 million holdings threshold to file a report that shows their positions at the end of...
5 Best Pharmaceutical Stocks to Buy According to Cathie Wood
In this article we discuss the 5 best pharmaceutical stocks to buy according to Cathie Wood.
Is INCY Stock A Buy or Sell?
At Insider Monkey, we pore over the filings of nearly 887 top investment firms every quarter, a process we have now completed for the latest reporting period.
5 Best Biotech Stocks To Buy For 2021
In this article we discuss the 5 best BioTech stocks to buy for 2021.
Is INCY A Good Stock To Buy According To Hedge Funds?
After several tireless days we have finished crunching the numbers from nearly 817 13F filings issued by the elite hedge funds and other investment firms that we track at Insider...
Incyte Corporation (INCY) Fell Out Of Favor With Hedge Funds
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings.
Hedge Fund and Insider Trading News: Bill Ackman, Anthony Scaramucci, Crispin Odey, Toscafund Asset Management, Incyte Corporation (INCY), Intellicheck Inc (IDN), and More
Bill Ackman is putting a modern-day spin on a centuries-old financial innovation with the special purpose acquisition company he plans to take public.
Were Hedge Funds Right About Incyte Corporation (INCY)?
We know that hedge funds generate strong, risk-adjusted returns over the long run, which is why imitating the picks that they are collectively bullish on can be a profitable strategy...
Hedge Funds Souring On Incyte Corporation (INCY)
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
Were Hedge Funds Right About Incyte Corporation (INCY)?
Coronavirus is probably the #1 concern in investors' minds right now. It should be.
Hedge Funds Started Buying Incyte Corporation (INCY) Too Early
Coronavirus is probably the #1 concern in investors’ minds right now. It should be.
How Did Incyte Corporation (INCY) Compare Against Top Hedge Fund Stocks in 2019?
We are still in an overall bull market and many stocks that smart money investors were piling into surged in 2019.
Did Hedge Funds Drop The Ball On Incyte Corporation (INCY) ?
Last year's fourth quarter was a rough one for investors and many hedge funds, which were naturally unable to overcome the big dip in the broad market, as the S&P 500 fell by ...
Were Hedge Funds Right About Dumping Incyte Corporation (INCY)?
Our extensive research has shown that imitating the smart money can generate significant returns for retail investors, which is why we track nearly 750 active prominent money ...
Here’s What Hedge Funds Think About Incyte Corporation (INCY)
Is Incyte Corporation (NASDAQ:INCY) a good stock to buy right now? We at Insider Monkey like to examine what billionaires and hedge funds think of a company before doing days ...
Did Hedge Funds Drop The Ball On Incyte Corporation (INCY) ?
Many investors, including Paul Tudor Jones or Stan Druckenmiller, have been saying before the Q4 market crash that the stock market is overvalued due to a low interest rate environment...
Is Incyte Corporation (INCY) A Good Stock To Buy?
Investing in hedge funds can bring large profits, but it’s not for everybody, since hedge funds are available only for high-net-worth individuals.
Insider Buying Roundup: Elon Musk Buys Tesla (TSLA) Shares After Earnings Call Backlash
Tesla Motors Inc (NASDAQ:TSLA) CEO Elon Musk has made amends with investors of his company after a poorly handled earnings call last week sent shares of the electric automaker...
Wondering What’s Happening in the Financial Markets Today? Take a Look at These 34 Stories!
"Stocks rose on Wall Street on Thursday, capping a wave of declines in major world equity markets triggered by uncertainty over U.S.
What’s Going On In The Finance World Today?
"U.S. equities rose on Monday as a weekend filled with geopolitical worries ended more calmly than investors expected, while bank stocks charged ahead.
Why Incyte Corporation (INCY) is in the Spotlight
Traders are watching Incyte Corporation (NASDAQ:INCY) after Geoff Meacham of Barclays hiked his price target on the biotech to $185 per share from $135.
11 Fastest Growing S&P 500 Companies in America
If, back in 2013, you invested in at least one of the 11 fastest growing S&P 500 companies in America, chances are that you are one happy (and possibly much wealthier) shareholder...
Does Incyte Corporation (INCY) Represent a Good Addition to Your Portfolio?
The market has been volatile due to elections and the potential of another Federal Reserve rate increase.
10 Most Successful Innovative Companies in The World in 2016
Bringing something new to the table is something that seems to be difficult these days, considering that many things have already been done, have already been invented, and have...
Stumbling Biotech Stocks Spell Doom for Baker Bros. Advisors
While several hedge funds have suffered enormous losses this year due to their investments in biotech stocks, the performance of the leading biotech-focused hedge fund Baker Bros...
Billionaire Leone Boosts Stake in This REIT, Ubben Sells More Shares of Motorola Solutions Inc. (MSI), Plus Two Other Hot Moves
It is generally believed that individuals seeking to become millionaires (and who isn't?) need to think and act like millionaires.
Healthcare-focused Baker Bros. Advisors’ Top Picks: Incyte, Alexion, ACADIA & More
Baker Bros. Advisors is a New York City-based fund launched in 2000 by Julian and Felix Baker.
